Rocular Eye Drops

About Rocular .2 % Eye Drops

Rocular is an eye drop medicine from G. A. Company Ltd. containing Brimonidine Tartrate at a strength of .2 %. It is used in eye care for people with certain pressure-related eye conditions.

There are 3 brands of Brimonidine Tartrate listed in Bangladesh.

What is Rocular .2 % Eye Drops?

Rocular eye drops are a prescription eye medicine with the active ingredient Brimonidine Tartrate at a strength of .2 %. It belongs to a group of drugs used for glaucoma and related eye pressure problems. It works by lowering raised pressure inside the eye in people with open-angle glaucoma or ocular hypertension. The doctor decides whether it is suitable and how it should be used. Always follow the eye specialist's instructions and ask the pharmacist if anything is unclear.

Uses of Rocular

Rocular eye drops are used to lower raised pressure inside the eye in adults with open-angle glaucoma or ocular hypertension. It is a medicine for eye pressure control and is not for treating other eye infections or general pain. The eye doctor decides if it is right for you after examining your eyes. Do not use it for any other purpose without medical advice.

How to use Rocular

Use Rocular eye drops only as your eye doctor instructs. The doctor decides the dose and course for you. Wash your hands before use and avoid letting the dropper tip touch your eye, eyelid or any surface. If you use other eye drops, ask your doctor or pharmacist how to space them. Do not stop or change use on your own. Ask your doctor or pharmacist if you are unsure how to put in eye drops.

Side effects of Rocular

Some people may notice dry mouth, redness, burning or stinging, headache, blurred vision, a feeling of something in the eye, tiredness or drowsiness, or itchy eyes. Other effects can include eye pain, dryness, tearing, dizziness or eyelid swelling. Call your doctor if side effects are severe, do not settle, or if you notice any eye or vision problem. Ask your pharmacist about anything that worries you.

Safety and precautions

Tell your doctor before using Rocular if you have severe heart disease, depression, poor circulation, low blood pressure on standing, or other serious health problems. It is not for people allergic to Brimonidine Tartrate or those taking MAO inhibitor medicines. Pregnancy and breastfeeding need medical advice, as there is limited information on use in these situations. The doctor will decide if it is suitable. Ask your doctor or pharmacist first if you have concerns.

Frequently asked questions

What does the generic name Brimonidine Tartrate mean?

Brimonidine Tartrate is the active ingredient in Rocular eye drops. It is a medicine that helps lower raised pressure inside the eye. The brand name Rocular is the product made by G. A. Company Ltd. Your doctor or pharmacist can explain more about how it works.

What is Rocular used for and what kind of medicine is it?

Rocular eye drops are used to lower raised pressure inside the eye in people with open-angle glaucoma or ocular hypertension. It is a medicine for glaucoma and eye pressure control. It is not for eye infections or general pain. Your eye doctor will decide if it is right for you.

What side effects should I watch for and when should I call the doctor?

Watch for dry mouth, eye redness, burning or stinging, headache, blurred vision, tiredness or itchy eyes. Call your doctor if these are severe or do not go away, or if you have any eye or vision problem. Ask your pharmacist about any other effect that worries you.

Can I use Rocular with other eye drops?

Your doctor will decide whether Rocular can be used with other eye medicines. If more than one eye drop is prescribed, ask your doctor or pharmacist how to space them. Do not start or stop other eye medicines without medical advice.

Indications

Brimonidine Tartrate 0.2% ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Brimonidine Tartrate 0.15% ophthalmic solution is indicated for the control of intraocular pressure in patients with chronic open-angle ... Read moreBrimonidine Tartrate 0.2% ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Brimonidine Tartrate 0.15% ophthalmic solution is indicated for the control of intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.

Brimonidine Tartrate 0.025% ophthalmic solution relieves redness of the eye due to minor eye irritations.

Pharmacology

Brimonidine is an α-2 adrenoreceptor agonist that is more selective for the α-2 adrenoreceptor than α-1. Topical administration of Brimonidine Tartrate eye drops decreases intraocular pressure (IOP) in humans. When used as directed Brimonidine Tartrate have the action of reducing elevated IOP with minimal effect on cardiovascular parametres. Brimonidine Tartrate eye drops have a rapid onset of action with the peak ocular hypotensive effect occurring at two hours post-dosing. The duration of effect is 12 hours or greater. Fluorophotometric studies in animals and humans suggest that Brimonidine Tartrate has a dual mechanism of action. Brimonidine Tartrate eye drops lower IOP by reducing aqueous humor production and enhancing uveoscleral outflow.

Dosage & Administration

0.2% ophthalmic solution: The recommended dose is one drop of 0.2% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart. This ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

0.15% ophthalmic solution: The recommended dose is one drop of 0.15% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.

0.025% ophthalmic solution: Instill 1 drop in the affected eye(s) every 6-8 hours. Do not use it more than 4 times daily. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

Interaction

Although specific drug interaction studies have not been conducted with Brimonidine Tartrate ophthalmic solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be considered. Alpha-agonists, as a class, may reduce pulse and blood pressure. Caution in using concomitant drugs such as beta-blockers (ophthalmic and systemic), antihypertensives and/or cardiac glycosides is advised. Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine. It is not known whether the concurrent use of these agents with Brimonidine Tartrate ophthalmic solution in humans can lead to resulting interference with the IOP lowering effect. No data on the level of circulating catecholamines after administration of Brimonidine Tartrate ophthalmic solution are available. Caution, however, is advised in patients taking Tricyclic antidepressants which can affect the metabolism and uptake of circulating amines.

Contraindications

Brimonidine Tartrate ophthalmic solution is contraindicated in patients with hypersensitivity to Brimonidine Tartrate. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.

Side Effects

Adverse events occurring in approximately 10-30% of the subjects, in descending order of incidence, included oral dryness, ocular hyperemia, burning and stinging, headache, blurring, foreign body sensation, fatigue/drowsiness, conjunctival follicles, ocular allergic reactions, and ocular pruritus. Events occurring in approximately 3-9% of the subjects, in descending order included corneal staining/erosion, photophobia, eyelid erythema, ocular ache/pain, ocular dryness, tearing, upper respiratory symptoms, eyelid edema, conjunctival edema, dizziness, blepharitis, ocular irritation, gastrointestinal symptoms, asthenia, conjunctival blanching, abnormal vision and muscular pain. The following adverse reactions were reported in less than 3% of the patients: lid crusting, conjunctival hemorrhage, abnormal taste, insomnia, conjunctival discharge, depression, hypertension, anxiety, palpitations/arrhythmias, nasal dryness and syncope.

Pregnancy & Lactation

There are no adequate and well-controlled studies in pregnant women. In animal studies, Brimonidine crossed the placenta and entered into the fetal circulation to a limited extent. Brimonidine Tartrate ophthalmic solution 0.2% should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk; in animal studies Brimonidine Tartrate was excreted in breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Although Brimonidine Tartrate ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. Brimonidine Tartrate ophthalmic solution should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension or thromboangiitis obliterans.

Storage Conditions

Store below 30°C in a cool and dry place protected from light. Keep out of reach of children. Do not touch the dropper tip to surfaces since this may contaminate the solution. Do not use after 30 days of first opening.

Alternative brands of Brimonidine Tartrate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.